Xbrane Biopharma

Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) announces that members of Xbrane's management team have sold shares to pay taxes that arose in connection with the allotment of shares under a long term incentive program. Martin Åmark has sold 27,000 shares and has a remaining ownership of 171,490 shares. Siavash Bashiri has sold 10,179 shares and has a remaining ownership of 120,714 shares.

“The sale is made solely to pay taxes that arose due to the allotment of shares from our long term incentive program and our remaining holdings in Xbrane are still by far our largest private financial investments. Our commitment and strong belief in Xbrane's future prospects remains, ”says Martin Åmark, CEO of Xbrane